Replies to post #221392 on Biotech Values

[jbog]

Does anyone know what the 'commission' that Abbvie will receive from all their biosimilar agreements. How long will they receive commissions?

[rfj1862]

I think you all are assuming that the biosimilars will be hugely less expensive than the branded treatments. They won't, so I don't expect Humira sales will take the kind of hit small molecules do when they go generic.

There are also very significant questions as to whether "biosimilars" are really all that similar. I think these concerns are justified, unlike the argument that Pfizer's small molecule is somehow better than Teva's small molecule.